Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesVentriPoint Diagnostics Ltd

VentriPoint Diagnostics Ltd

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.0495 USD 0.00(0%)
Last update at 2026-11-05T21:00:00Z
VOLUME
60000
Market Cap
13.21M

Momentum Score

…

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.05
Low
0.05
High
52 Week Price Range
0.06
Low
0.14
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.05
Dividend Yield
-
Revenue TTM
0.15M
Revenue Per Share
0.00
Gross Profit TTM
0.15M
Debt / Equity
-0.63
ROE
-2972.60%
Net Debt
2.54M
ROCE
84.96%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -3.25M -5.00M -4.87M -4.87M -3.88M
Net income -3.20M -4.92M -4.87M -4.87M -3.88M
Selling general administrative 2.45M 2.57M 2.81M 3.87M 3.22M
Selling and marketing expenses 0.76M 1.36M 1.08M - -
Gross profit 0.12M 0.10M 0.04M 0.06M 0.00M
Reconciled depreciation 0.06M 0.06M 0.07M 0.05M 0.05M
Ebit -3.40M -4.82M -4.81M - -
Ebitda -3.34M -4.76M -4.75M -4.79M -3.82M
Depreciation and amortization 0.06M 0.06M 0.07M - -
Operating income -3.40M -4.80M -4.93M -4.91M -3.72M
Other operating expenses 3.58M 4.90M 4.98M - -
Interest expense 0.53M 0.18M 0.06M 0.03M 0.01M
Tax provision -0.05M -0.08M 0.00M - -
Interest income 0.01M 0.01M 0.08M 0.03M 0.05M
Net interest income -0.52M -0.18M 0.01M -0.01M 0.03M
Income tax expense -0.05M -0.08M - - -
Total revenue 0.18M 0.10M 0.05M 0.07M 0.00M
Total operating expenses 3.52M 4.90M 4.97M 4.98M 3.72M
Cost of revenue 0.06M 0.04M 0.01M 0.01M 0.00M
Total other income expense net 0.15M -0.20M 0.06M 0.05M -0.20M
Net income from continuing ops -3.20M -4.92M -4.87M -4.87M -3.88M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 0.47M 0.66M 1.88M 5.98M 9.54M
Other current assets 0.16M 0.16M 0.06M - -
Total liab 4.58M 3.64M 1.69M 1.42M 1.21M
Total stockholder equity -4.11M -2.98M 0.19M 4.55M 8.33M
Other current liab 1.01M 0.29M 0.30M - -
Common stock 44.73M 43.78M 42.68M - -
Capital stock 44.77M 43.78M 42.68M 42.68M 42.21M
Retained earnings -61.56M -58.41M -53.49M -48.62M -43.75M
Cash 0.06M 0.06M 1.29M 5.19M 9.27M
Total current liabilities 4.47M 3.43M 1.40M 1.06M 1.09M
Current deferred revenue 0.02M 0.01M 0.03M - -
Net debt 2.54M 1.57M -0.88M - -
Short term debt 2.50M 1.42M 0.12M - -
Short long term debt 2.42M 1.36M 0.06M 0.05M -
Short long term debt total 2.60M 1.63M 0.41M - -
Other stockholder equity 12.21M 11.61M 10.91M - -
Total current assets 0.35M 0.47M 1.64M 5.66M 9.50M
Net receivables 0.13M 0.25M 0.29M 0.04M -
Long term debt 0.04M 0.06M 0.08M 0.09M 0.13M
Inventory - - -0.29M - -
Accounts payable 0.95M 1.70M 0.95M 0.84M 0.99M
Accumulated other comprehensive income 0.51M 0.05M 0.09M - -
Non current assets total 0.12M 0.18M 0.25M 0.31M 0.04M
Capital lease obligations 0.15M 0.22M 0.27M 0.32M 0.03M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - - - 0.00M -0.00M
Net borrowings 1.19M 1.52M -0.10M - -
Total cash from financing activities 1.53M 2.20M -0.10M 0.09M 11.89M
Net income -3.20M -4.92M -4.87M -4.87M -3.88M
Change in cash -0.00M -1.23M -3.89M -4.08M 8.74M
Begin period cash flow 0.06M 1.29M 5.19M 9.27M 0.53M
End period cash flow 0.06M 0.06M 1.29M 5.19M 9.27M
Total cash from operating activities -1.55M -3.39M -3.80M -4.14M -3.15M
Issuance of capital stock 0.00M 0.55M 0.00M 0.00M 8.06M
Depreciation 0.06M 0.06M 0.07M 0.05M 0.05M
Dividends paid 0.00M 0.00M 0.00M - -
Change to inventory - - - - 0.00M
Change to account receivables 0.12M 0.03M 0.09M - -
Other cashflows from financing activities 0.03M 0.13M -0.08M - -
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 1.08M 0.70M 0.45M -0.33M -0.46M
Stock based compensation 0.71M 0.68M 0.49M 0.80M 0.90M
Other non cash items -0.16M 0.17M 0.06M 0.22M -0.03M
Free cash flow -1.55M -3.39M -3.80M -4.14M -3.15M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
VPTDF
VentriPoint Diagnostics Ltd		 -
-%		 0.05 - - 89.41 7.05 132.91 -4.90
ABT
Abbott Laboratories		 -0.03
0.03%		 109.93 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 -3.04
2.90%		 101.80 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -9.21
2.75%		 325.87 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -2.15
4.12%		 49.85 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

VentriPoint Diagnostics Ltd

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.

18 Hook Avenue, Toronto, ON, Canada, M6P 1T4

416 848 4156

https://ventripoint.com

Name Title Year Born
Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D. Exec. Chairman & Interim CEO 1952
Mr. Victor Hugo C.M.A., CPA Chief Financial Officer 1970
Dr. Alvira Macanovic Ph.D. VP of Operations, Regulatory Affairs & Quality Assurance NA
Mr. Hirotaka Katagiri CTO & Bus. Devel. Division Director NA
Ms. Jessica Naman Director of Marketing NA
Mr. Desmond Hirson Consultant NA
Mr. Jim Graba Application Specialist & Chief Trainer NA
Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D. Executive Chairman & Corporate Secretary 1952
Mr. Hugh MacNaught CEO, President & Director NA
Mr. David Swetlow C.A., CPA Chief Financial Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…